A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:February 16, 2023Active, not recruiting